PharmaVigilant Selected by Spectrum Pharmaceuticals, Inc. (SPPI) to Support 10 Studies
4/10/2012 10:19:38 AM
WESTBOROUGH, Mass.--(BUSINESS WIRE)--PharmaVigilant, an e-clinical provider, today announced that US based Spectrum Pharmaceuticals has selected I-Vault as it’s electronic Trial Master File Platform. Spectrum, a pharmaceutical company focused on oncology drugs and unmet medical needs will standardize on the PharmaVigilant solution.
|